Accendra Health: Bank of America reports 10.8% stake
Accendra Health Inc. is the issuer named in a Schedule 13G in which Bank of America Corporation reported beneficial ownership of 8,270,614 common shares, representing 10.8% of the class, as of September 30, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Accendra Health Inc. is the issuer named in a Schedule 13G in which Bank of America Corporation reported beneficial ownership of 8,270,614 common shares, representing 10.8% of the class, as of September 30, 2026. It reported shared voting power over 1,349,537 shares and shared dispositive power over 8,270,614 shares, with no sole voting or dispositive power.
Bank of America Corporation filed on behalf of itself and its wholly owned subsidiaries BofA Securities, Inc., Bank of America, N.A., Merrill Lynch International, and Merrill Lynch Pierce Fenner & Smith, Inc.
Key Figures
Key Terms
beneficial ownership regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.